GlassScriptPhysician profile
Felecia Brown
NPI 1598902447
$2,983.79
in general payments reported to CMS, 2019-2025
13 companies · $146 in 2025
The $146 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $889 · 2022: $935 · 2023: $685 · 2024: $328 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $692.03 | 2021-2024 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $585.56 | 2021-2023 | Uzedy, Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $477.29 | 2021-2024 | Caplyta |
| Alkermes, INC. | $471.72 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $338.09 | 2022-2024 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Organon LLC | $179.49 | 2021-2025 | Jada System |
| Abbvie INC. | $109.47 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $33.06 | 2021 | |
| Lundbeck LLC | $29.43 | 2022 | |
| Mayne Pharma Commercial LLC | $20.83 | 2023 | |
| Therapeuticsmd, INC. | $20.75 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.39 | 2023 | |
| Avion Pharmaceuticals | $11.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felecia Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.